Synalgos-DC

Synalgos-DC is a brand name of aspirin/caffeine/dihydrocodeine, approved by the FDA in the following formulation(s):

SYNALGOS-DC (aspirin; caffeine; dihydrocodeine bitartrate - capsule; oral)

• 
  Manufacturer: CARACO
  
  Approval date: September 6, 1983
  
  Strength(s): 356.4MG;30MG;16MG ^[RLD]

Has a generic version of Synalgos-DC been approved?

No. There is currently no therapeutically equivalent version of Synalgos-DC available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Synalgos-DC. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Synalgos-DC.

See also...

• Synalgos-DC Consumer Information (Wolters Kluwer)
• Synalgos-DC Consumer Information (Cerner Multum)
• Synalgos-DC Advanced Consumer Information (Micromedex)
• Aspirin/Caffeine/Dihydrocodeine Consumer Information (Wolters Kluwer)
• Aspirin, caffeine, and dihydrocodeine Consumer Information (Cerner Multum)
• Dihydrocodeine, aspirin, and caffeine Advanced Consumer Information (Micromedex)